Pharmacyclics, Inc. (PCYC) Tops Q2 EPS by 33c
Tweet Send to a FriendGet Alerts PCYC Hot Sheet
Price: $88.26 +1.23%
EPS Growth %: -24.4%
Financial Fact:
Total revenues: 102.7M
Today's EPS Names:
CO, JW-A, FDS, More
EPS Growth %: -24.4%
Financial Fact:
Total revenues: 102.7M
Today's EPS Names:
CO, JW-A, FDS, More
Trade PCYC Now!
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of $0.62, $0.33 better than the analyst estimate of $0.29. Revenue for the quarter came in at $57.96 million versus the consensus estimate of $45.74 million.
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
- Updated Results of Two Phase 2 Ibrutinib Studies in Patients with Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
- Capstone Turbine Corp (CPST) Reports In-Line Q4 EPS of 1c/Share
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
